Search

Hikma Pharmaceuticals PLC

Abrir

SetorSaúde

1,898 -1.35

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1877

Máximo

1928

Indicadores-chave

By Trading Economics

Rendimento

-93M

133M

Vendas

-11M

1.6B

P/E

Médio do Setor

15.451

57.333

EPS

1.27

Rendimento de Dividendos

3.24

Margem de lucro

8.537

Funcionários

9,500

EBITDA

-211M

288M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+27.23% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

3.24%

2.63%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-930M

4.2B

Abertura anterior

1899.35

Fecho anterior

1898

Hikma Pharmaceuticals PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

8 de abr. de 2025, 08:20 UTC

Conversa de Mercado

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

Hikma Pharmaceuticals PLC Previsão

Preço-alvo

By TipRanks

27.23% parte superior

Previsão para 12 meses

Média 2,422.5 GBX  27.23%

Máximo 2,650 GBX

Mínimo 2,000 GBX

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Hikma Pharmaceuticals PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

7 ratings

5

Comprar

2

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.